CN113785929A - 一种缓解痛风的植物复配固体饮料 - Google Patents
一种缓解痛风的植物复配固体饮料 Download PDFInfo
- Publication number
- CN113785929A CN113785929A CN202111149760.5A CN202111149760A CN113785929A CN 113785929 A CN113785929 A CN 113785929A CN 202111149760 A CN202111149760 A CN 202111149760A CN 113785929 A CN113785929 A CN 113785929A
- Authority
- CN
- China
- Prior art keywords
- parts
- solid beverage
- pawpaw
- gout
- compound solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 54
- 235000013361 beverage Nutrition 0.000 title claims abstract description 47
- 239000007787 solid Substances 0.000 title claims abstract description 46
- 150000001875 compounds Chemical class 0.000 title claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims description 40
- 244000189799 Asimina triloba Species 0.000 claims description 24
- 235000006264 Asimina triloba Nutrition 0.000 claims description 24
- 235000009467 Carica papaya Nutrition 0.000 claims description 24
- 241000270273 Ptyas dhumnades Species 0.000 claims description 23
- 210000003038 endothelium Anatomy 0.000 claims description 23
- 241001598107 Imperata Species 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 19
- 241000208340 Araliaceae Species 0.000 claims description 18
- 240000003915 Lophatherum gracile Species 0.000 claims description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 18
- 235000008434 ginseng Nutrition 0.000 claims description 18
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 17
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 17
- 229930006000 Sucrose Natural products 0.000 claims description 17
- 239000000600 sorbitol Substances 0.000 claims description 17
- 229960004793 sucrose Drugs 0.000 claims description 17
- 244000025254 Cannabis sativa Species 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 13
- 235000008708 Morus alba Nutrition 0.000 claims description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 13
- 235000011477 liquorice Nutrition 0.000 claims description 13
- 244000077995 Coix lacryma jobi Species 0.000 claims description 12
- 241000234435 Lilium Species 0.000 claims description 12
- 244000197580 Poria cocos Species 0.000 claims description 12
- 235000008599 Poria cocos Nutrition 0.000 claims description 12
- 240000000249 Morus alba Species 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 241000572565 Alpinia oxyphylla Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 241000218231 Moraceae Species 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 240000007171 Imperata cylindrica Species 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 3
- 208000006820 Arthralgia Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 206010023232 Joint swelling Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000005392 Spasm Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 208000006083 Hypokinesia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000031877 prophase Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明属于固体饮料技术领域,且公开了一种缓解痛风的植物复配固体饮料,本发明的固体饮料所用的配方药材中,以木瓜、乌梢蛇、人参、益智仁、鸡内金为主药,以薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、白茅根为佐药,以蔗糖和山梨糖醇作为辅料,通过制得的植物固体饮料,基于中医药理论,通过上述药物的配伍,对于痛风前期引起的关节疼痛,乏力,发热等症状,有良好的缓解作用。本发明的植物固体饮料可通过开水冲调,即可饮用,方便日常使用,同时也可改善人体机能,提高人体的健康水平。
Description
技术领域
本发明属于固体饮料技术领域,具体是一种缓解痛风的植物复配固体饮料。
背景技术
我国缺乏全国范围痛风流行病学调查资料,但根据不同时间、不同地区报告的痛风患病情况,目前我国痛风的患病率在1%-3%,并呈逐年上升趋势。
《2016年中国痛风诊疗指南》显示,痛风患者最主要的就诊原因是关节痛(男性为41.2%,女性为29.8%),其次为乏力和发热。
男女发病诱因有很大差异,男性患者最主要为饮酒诱发(25.5%),其次为高嘌呤饮食(22.9%)和剧烈运动(6.2%);女性患者最主要为高嘌呤饮食诱发(17.0%),其次为突然受冷(11.2%)和剧烈运动(9.6%)。加上,现在社会中,生活和工作的压力,导致人们摄入更多的高嘌呤食物(酒和肉类),导致痛风的发病率逐渐年轻化。
在痛风前期,就有关节疼痛,乏力,发热等症状,痛风中期和后期,患者的关节疼痛,肿胀更为严重,目前主要是通过控制饮食来减少体内的尿酸排出,使用常规药物治疗时,对身体机能有影响,且不方便日常生活。
发明内容
本发明的目的是针对以上问题,本发明提供了一种可日常方便饮用,且可有效缓解痛风症状的植物固体饮料。
为实现上述目的,本发明提供如下技术方案:
一种缓解痛风的植物复配固体饮料,由以下重量份数的原料药组成:木瓜30-40份,薏苡仁15-20份,茯苓15-20份,桑葚12-15份,百合12-15份,甘草10-12份,淡竹叶12-15份,白茅根10-15份,乌梢蛇10-12份,人参6-10份,益智仁12-15份,鸡内金12-15份,蔗糖30-35份,山梨糖醇40-45份,且木瓜和乌梢蛇的重量比为20-10:1。
作为本发明的一种优选技术方案,由以下重量份数的原料药组成:木瓜32份,薏苡仁16份,茯苓17份,桑葚13份,百合14份,甘草10份,淡竹叶12份,白茅根15份,乌梢蛇10份,人参7份,益智仁12份,鸡内金12份,蔗糖30份,山梨糖醇45份,且木瓜和乌梢蛇的重量比为20-10:1。
作为本发明的一种优选技术方案,由以下重量份数的原料药组成:木瓜30份,薏苡仁20份,茯苓15份,桑葚12份,百合15份,甘草10份,淡竹叶15份,白茅根10份,乌梢蛇12份,人参6份,益智仁15份,鸡内金12份,蔗糖35份,山梨糖醇40份,且木瓜和乌梢蛇的重量比为20-10:1。
作为本发明的一种优选技术方案,由以下重量份数的原料药组成:木瓜40份,薏苡仁15份,茯苓20份,桑葚12份,百合15份,甘草12份,淡竹叶12份,白茅根15份,乌梢蛇10份,人参10份,益智仁12份,鸡内金15份,蔗糖33份,山梨糖醇44份,且木瓜和乌梢蛇的重量比为20-10:1。
作为本发明的一种优选技术方案,所述鸡内金与益智仁的重量比为10-5:1。
作为本发明的一种优选技术方案,所述白茅根与淡竹叶的重量比为10-8:1。
一种缓解痛风的植物复配固体饮料的制备方法,包括以下步骤:
原料处理,将木瓜、薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、鲜白茅根、乌梢蛇、人参、益智仁去除其中杂质,洗净,晾干,破碎成长度为1-3cm的碎块,鸡内金研磨成粉状;
煎煮,按照配比将预处理后的上述药材,加入20倍量的水,煎煮2-3次,每次沸腾后保持沸腾30-45分钟;
过滤,合并上述煎煮液,过滤;
浓缩,将滤液浓缩至相对密度为1.2±0.05,在55-60℃的条件下,将浓缩液进行过滤;
干燥,得到提取物粉末;
混合,按照配比将蔗糖和山梨糖醇粉碎过目筛与上述提取物粉末混合均匀;
装袋,将上述得到的植物固体饮料混合物,按每袋30克装袋,密封。
与现有技术相比,本发明的有益效果如下:
1、本发明的固体饮料所用的配方药材中,以木瓜、乌梢蛇、人参、益智仁、鸡内金为主药,以薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、白茅根为佐药,以蔗糖和山梨糖醇作为辅料,其中木瓜有舒筋活络,和胃化湿的功效,用于治疗湿痹拘挛,腰膝关节酸重疼痛,暑湿吐泻,转筋挛痛,脚气水肿;薏苡仁有利水渗透湿,健脾止泻,除痹,排脓,解毒散结的作用,用于水肿,脚气,小便不利,脾虚泄泻,湿痹拘挛,肺痈,肠痈;赘疣,癌肿;茯苓可利水渗湿,健脾,宁心,用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠;桑葚有很好的滋补心、肝、肾,及养血祛风的功效,对降脂和减轻神经衰弱、动脉硬化、性功能衰弱、耳聋眼花、须发早白、内热消渴、血虚便秘、风湿关节疼痛均有显著疗效;百合养阴润肺,清心安神,用于阴虚燥咳,劳嗽咳血,虚烦惊悸,失眠多梦,精神恍惚;甘草用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力等;淡竹叶有清凉,解热、利尿及催产之效;主治:胸中疾热、咳逆上气、吐血、热毒风、止消渴、压丹石毒、消痰、治热狂烦闷、中风失音不语、痛头风、止惊悸、瘟疫迷闷、杀小虫、除热缓脾;白茅根凉血止血,清热利尿,用于血热吐血,衄血,尿血,热病烦渴,肺热咳嗽,胃热呕吐,湿热黄疸,水肿尿少,热淋涩痛;乌梢蛇祛风湿,通经络,止痉,主治风湿顽痹,肌肤麻木,筋脉拘挛,肢体瘫痪,破伤风,麻风,风疹疥癣;人参主治大补元气,复脉固脱,补脾益肺,生津,安神。用于体虚欲脱、肢冷脉微、脾虚食少、肺虚喘咳、津伤口渴;益智仁可温脾止泻摄涎,暖肾缩尿固精,主治脾胃虚寒,呕吐,泄泻,腹中冷痛,口多唾涎,肾虚遗尿;鸡内金健胃消食,涩精止遗,通淋化石,用于食积不消,呕吐泻痢,小儿疳积,遗尿,遗精,石淋涩痛,胆胀胁痛。本发明是植物固体饮料,基于中医药理论,通过上述药物的配伍,对于痛风前期引起的关节疼痛,乏力,发热等症状,有良好的缓解作用。
2、本发明的植物固体饮料可通过开水冲调,即可饮用,方便日常使用,同时也可改善人体机能,提高人体的健康水平。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例一
一种缓解痛风的植物复配固体饮料,由以下重量份数的原料药组成:木瓜32份,薏苡仁16份,茯苓17份,桑葚13份,百合14份,甘草10份,淡竹叶12份,白茅根15份,乌梢蛇10份,人参7份,益智仁12份,鸡内金12份,蔗糖30份,山梨糖醇45份,且木瓜和乌梢蛇的重量比为20:1,鸡内金与益智仁的重量比为8:1,白茅根与淡竹叶的重量比为10:1。
原料处理,将木瓜、薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、鲜白茅根、乌梢蛇、人参、益智仁去除其中杂质,洗净,晾干,破碎成长度为1-3cm的碎块,鸡内金研磨成粉状;
煎煮,按照配比将预处理后的上述药材,加入20倍量的水,煎煮2-3次,每次沸腾后保持沸腾45分钟;
过滤,合并上述煎煮液,过滤;
浓缩,将滤液浓缩至相对密度为1.2±0.05,在55-60℃的条件下,将浓缩液进行过滤;
干燥,得到提取物粉末;
混合,按照配比将蔗糖和山梨糖醇粉碎过目筛与上述提取物粉末混合均匀。
将上述得到的植物固体饮料混合物,按每袋30克装袋,密封;饮用时,撕开包装袋,导入杯中,加入200ml开水,搅拌均匀得到缓解痛风的植物复配固体饮料。
实施例二
一种缓解痛风的植物复配固体饮料,由以下重量份数的原料药组成:木瓜30份,薏苡仁20份,茯苓15份,桑葚12份,百合15份,甘草10份,淡竹叶15份,白茅根10份,乌梢蛇12份,人参6份,益智仁15份,鸡内金12份,蔗糖35份,山梨糖醇40份,且木瓜和乌梢蛇的重量比为15:1,鸡内金与益智仁的重量比为10:1,白茅根与淡竹叶的重量比为8:1。
原料处理,将木瓜、薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、鲜白茅根、乌梢蛇、人参、益智仁去除其中杂质,洗净,晾干,破碎成长度为1-3cm的碎块,鸡内金研磨成粉状;
煎煮,按照配比将预处理后的上述药材,加入20倍量的水,煎煮2-3次,每次沸腾后保持沸腾30分钟;
过滤,合并上述煎煮液,过滤;
浓缩,将滤液浓缩至相对密度为1.2±0.05,在55-60℃的条件下,将浓缩液进行过滤;
干燥,得到提取物粉末;
混合,按照配比将蔗糖和山梨糖醇粉碎过目筛与上述提取物粉末混合均匀。
将上述得到的植物固体饮料混合物,按每袋30克装袋,密封;饮用时,撕开包装袋,导入杯中,加入200ml开水,搅拌均匀得到缓解痛风的植物复配固体饮料。
实施例三
一种缓解痛风的植物复配固体饮料,由以下重量份数的原料药组成:木瓜40份,薏苡仁15份,茯苓20份,桑葚12份,百合15份,甘草12份,淡竹叶12份,白茅根15份,乌梢蛇10份,人参10份,益智仁12份,鸡内金15份,蔗糖33份,山梨糖醇44份,且木瓜和乌梢蛇的重量比为10:1,鸡内金与益智仁的重量比为5:1,白茅根与淡竹叶的重量比为9:1。
原料处理,将木瓜、薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、鲜白茅根、乌梢蛇、人参、益智仁去除其中杂质,洗净,晾干,破碎成长度为1-3cm的碎块,鸡内金研磨成粉状;
煎煮,按照配比将预处理后的上述药材,加入20倍量的水,煎煮2-3次,每次沸腾后保持沸腾35分钟;
过滤,合并上述煎煮液,过滤;
浓缩,将滤液浓缩至相对密度为1.2±0.05,在55-60℃的条件下,将浓缩液进行过滤;
干燥,得到提取物粉末;
混合,按照配比将蔗糖和山梨糖醇粉碎过目筛与上述提取物粉末混合均匀。
将上述得到的植物固体饮料混合物,按每袋30克装袋,密封;饮用时,撕开包装袋,导入杯中,加入200ml开水,搅拌均匀得到缓解痛风的植物复配固体饮料。
实验方法:按照实施例1-3的使用方法进行实验,连续使用1个月,实验期间停止使用其他中西药及保健品。
效果验证:对临床诊断为痛风患者,能按医嘱配合治疗者,年龄在25-50周岁患者200名,分成A、B、C、D、E、F、G、H、I、J十组,每组20人。其中,A、B、C三组为痛风前期患者,D、E、F三组为痛风中期患者,G、H、I三组为痛风中期患者,J组为痛风前期患者。
A组使用由本发明上述实施例一制得的缓解痛风的植物复配固体饮料;
B组使用由本发明上述实施例二制得的缓解痛风的植物复配固体饮料;
C组使用由本发明上述实施例三制得的缓解痛风的植物复配固体饮料;
D组使用由本发明上述实施例一制得的缓解痛风的植物复配固体饮料;
E组使用由本发明上述实施例二制得的缓解痛风的植物复配固体饮料;
F组使用由本发明上述实施例三制得的缓解痛风的植物复配固体饮料;
G组使用由本发明上述实施例一制得的缓解痛风的植物复配固体饮料;
H组使用由本发明上述实施例二制得的缓解痛风的植物复配固体饮料;
I组使用由本发明上述实施例三制得的缓解痛风的植物复配固体饮料;
J组使用临床复配的营养饮料。
实验结果:
A组治疗痛风前期患者20例,关节疼痛、乏力缓解16例,有效率为80%,好转有3例,显效率为15%,无效1例,无效率为5%;
B组治疗痛风前期患者20例,关节疼痛、乏力缓解15例,有效率为75%,好转有4例,显效率为20%,无效1例,无效率为5%;
C治疗痛风前期患者20例,关节疼痛、乏力缓解17例,有效率为85%,好转有1例,显效率为5%,无效2例,无效率为10%;
D组治疗痛风中期期患者20例,关节疼痛、肿胀缓解14例,有效率为70%,好转有3例,显效率为15%,无效3例,无效率为15%;
E组治疗痛风中期期患者20例,关节疼痛、肿胀缓解11例,有效率为55%,好转有4例,显效率为20%,无效5例,无效率为25%;
F组治疗痛风中期期患者20例,关节疼痛、肿胀缓解12例,有效率为70%,好转有3例,显效率为15%,无效5例,无效率为25%;
G组治疗痛风中期期患者20例,关节疼痛、肿胀缓解10例,有效率为50%,好转有3例,显效率为15%,无效7例,无效率为35%;
H组治疗痛风中期期患者20例,关节疼痛、肿胀缓解10例,有效率为50%,好转有4例,显效率为20%,无效6例,无效率为30%;
I组治疗痛风中期期患者20例,关节疼痛、肿胀缓解9例,有效率为45%,好转有2例,显效率为10%,无效9例,无效率为45%;
J组治疗痛风中期期患者20例,关节疼痛、乏力缓解2例,有效率为10%,好转有1例,显效率为5%,无效17例,无效率为85%。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (7)
1.一种缓解痛风的植物复配固体饮料,其特征在于,由以下重量份数的原料药组成:木瓜30-40份,薏苡仁15-20份,茯苓15-20份,桑葚12-15份,百合12-15份,甘草10-12份,淡竹叶12-15份,白茅根10-15份,乌梢蛇10-12份,人参6-10份,益智仁12-15份,鸡内金12-15份,蔗糖30-35份,山梨糖醇40-45份,且木瓜和乌梢蛇的重量比为20-10:1。
2.根据权利要求1所述的一种缓解痛风的植物复配固体饮料,其特征在于,由以下重量份数的原料药组成:木瓜32份,薏苡仁16份,茯苓17份,桑葚13份,百合14份,甘草10份,淡竹叶12份,白茅根15份,乌梢蛇10份,人参7份,益智仁12份,鸡内金12份,蔗糖30份,山梨糖醇45份,且木瓜和乌梢蛇的重量比为20-10:1。
3.根据权利要求1所述的一种缓解痛风的植物复配固体饮料,其特征在于,由以下重量份数的原料药组成:木瓜30份,薏苡仁20份,茯苓15份,桑葚12份,百合15份,甘草10份,淡竹叶15份,白茅根10份,乌梢蛇12份,人参6份,益智仁15份,鸡内金12份,蔗糖35份,山梨糖醇40份,且木瓜和乌梢蛇的重量比为20-10:1。
4.根据权利要求1所述的一种缓解痛风的植物复配固体饮料,其特征在于,由以下重量份数的原料药组成:木瓜40份,薏苡仁15份,茯苓20份,桑葚12份,百合15份,甘草12份,淡竹叶12份,白茅根15份,乌梢蛇10份,人参10份,益智仁12份,鸡内金15份,蔗糖33份,山梨糖醇44份,且木瓜和乌梢蛇的重量比为20-10:1。
5.根据权利要求1-4任一项所述的一种缓解痛风的植物复配固体饮料,其特征在于:所述鸡内金与益智仁的重量比为10-5:1。
6.根据权利要求1-4任一项所述的一种缓解痛风的植物复配固体饮料,其特征在于:所述白茅根与淡竹叶的重量比为10-8:1。
7.如权利要求1-6任一项所述的一种缓解痛风的植物复配固体饮料的制备方法,其特征在于:包括以下步骤:
原料处理,将木瓜、薏苡仁、茯苓、桑葚、百合、甘草、淡竹叶、鲜白茅根、乌梢蛇、人参、益智仁去除其中杂质,洗净,晾干,破碎成长度为1-3cm的碎块,鸡内金研磨成粉状;
煎煮,按照配比将预处理后的上述药材,加入20倍量的水,煎煮2-3次,每次沸腾后保持沸腾30-45分钟;
过滤,合并上述煎煮液,过滤;
浓缩,将滤液浓缩至相对密度为1.2±0.05,在55-60℃的条件下,将浓缩液进行过滤;
干燥,得到提取物粉末;
混合,按照配比将蔗糖和山梨糖醇粉碎过目筛与上述提取物粉末混合均匀;
装袋,将上述得到的植物固体饮料混合物,按每袋30克装袋,密封。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111149760.5A CN113785929A (zh) | 2021-09-29 | 2021-09-29 | 一种缓解痛风的植物复配固体饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111149760.5A CN113785929A (zh) | 2021-09-29 | 2021-09-29 | 一种缓解痛风的植物复配固体饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113785929A true CN113785929A (zh) | 2021-12-14 |
Family
ID=78877661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111149760.5A Withdrawn CN113785929A (zh) | 2021-09-29 | 2021-09-29 | 一种缓解痛风的植物复配固体饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113785929A (zh) |
-
2021
- 2021-09-29 CN CN202111149760.5A patent/CN113785929A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105265672B (zh) | 一种核桃分心木茶的生产方法 | |
CN102382743B (zh) | 酒糟保健酒及其加工方法 | |
KR20090002854A (ko) | 생약 발모제 조성물 및 이의 제조방법 | |
CN104666896A (zh) | 一种治疗脂溢性脱发的内服药物及其制备方法 | |
CN105596858A (zh) | 一种治疗阴虚盗汗的中药组合物及其制备方法 | |
CN103141893B (zh) | 一种松针饮料及其制备方法 | |
CN105199911A (zh) | 一种黑糯米发酵饮料的制备方法 | |
CN113785929A (zh) | 一种缓解痛风的植物复配固体饮料 | |
CN104397236A (zh) | 平胃养生中药茶饮品及制备方法 | |
CN1969678A (zh) | 一种七雪神清凉茶及其制备方法 | |
CN105815660A (zh) | 一种瘦身营养粥 | |
CN111588029A (zh) | 一种黄精膏组合物 | |
CN111758905A (zh) | 一种祛湿健脾、排湿毒功效的养生食品 | |
CN105167097A (zh) | 一种黑糯米发酵饮料 | |
KR20070100064A (ko) | 면역력 강화에 효과가 있는 생약재 조성물 및 이를 티백형태로 제조하는 방법 | |
CN109464648A (zh) | 一种治疗癌症的中药及其制备方法 | |
CN108543049A (zh) | 一种通经活络伸筋茶及其制备方法 | |
CN106729206B (zh) | 具有健脾祛湿、行气利水功效的中药组合物、祛湿颗粒及其制备方法 | |
CN105012905A (zh) | 补虚生血通络酒 | |
CN105707321A (zh) | 一种减脂茶 | |
CN105567530A (zh) | 一种具有软化血管之功效的醋饮及其制备方法 | |
CN105106564A (zh) | 一种治疗咽喉肿痛的中药组合物 | |
CN111329960A (zh) | 一种用于治疗糖尿病的保健酒及其制备方法 | |
CN104547703A (zh) | 一种治疗小儿湿疹的中药组合物及其制备方法 | |
CN112022989A (zh) | 一种提高免疫力的肉灵芝口服液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20211214 |